share_log

HC Wainwright & Co. Reiterates Buy on Onconova Therapeutics, Maintains $11 Price Target

HC Wainwright & Co. Reiterates Buy on Onconova Therapeutics, Maintains $11 Price Target

HC Wainwright & Co.重申買入Onconova Therapeutics,維持11美元的目標股價
Benzinga ·  2023/06/06 06:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates Onconova Therapeutics (NASDAQ:ONTX) with a Buy and maintains $11 price target.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯重申Onconova Therapeutics(納斯達克股票代碼:ONTX)的買入並維持11美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論